Calorie intake and patient outcomes in severe acute kidney injury: findings from The Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy (RENAL) study trial
Rinaldo Bellomo, Alan Cass, Louise Cole, Simon Finfer, Martin Gallagher, Joanne Lee, Serigne Lo, Colin McArthur, Shay McGuinness, John Myburgh, Robyn Norton, Carlos Scheinkestel
Critical Care | BIOMED CENTRAL LTD | Published : 2014
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by Health Research Council (HRC) of New Zealand
This study was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (Grant No 352550) and Health Research Council (HRC) of New Zealand (Grant No 06-357). Professor Alan Cass was supported by a NHMRC Senior Research Fellowship. We thank Gambro for providing discounted pricing for Haemosol (TM) dialysate and replacement fluids and the nurses in our intensive care units, our physician colleagues, and our patients and their families for the support of this trial. The founding bodies had no involvement in the design, collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. The Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy (RENAL) study is a collaboration of the Australian and New Zealand Intensive Care Society Clinical Trials Group and the George Institute for International Health.